Local Therapy to the Primary Tumor for Newly Diagnosed, Oligo-Metastatic PC: A Prospective Randomized, Phase 2, Open-Label Trial

[tango65]

"With a median follow-up of 28 months, there was improved radiographic progression-free survival for those randomized to radical local therapy (median NR vs 50 months) (hazard ratio 0.50, 95% confidence interval 0.28 to 0.87, p=0.015)."

urotoday.com/conference-hig...

[George71]

Thanks Tango65 -- good stuff

[tango65]

Thanks. It is worrisome that in this group there are people against direct treatment of oligo metastatic cancer.